NCT00123760View on ClinicalTrials.gov

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

10,838

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Brain NeoplasmsLung NeoplasmsThyroid NeoplasmsColorectal NeoplasmsLymphoma
Interventions
PROCEDURE

Positron Emission Tomography (PET) scan

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
collaborator

Cross Cancer Institute

OTHER

lead

AHS Cancer Control Alberta

OTHER

NCT00123760 - Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | Biotech Hunter | Biotech Hunter